Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation

Hemoglobinopathies are among the most common monogenic diseases worldwide. Approximately 1–5% of the global population are carriers for a genetic thalassemia mutation. The thalassemias are characterized by autosomal recessive inherited defects in the production of hemoglobin. They are highly prevale...

Descripción completa

Detalles Bibliográficos
Autores principales: Motta, Irene, Bou-Fakhredin, Rayan, Taher, Ali T., Cappellini, Maria Domenica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299245/
https://www.ncbi.nlm.nih.gov/pubmed/32557398
http://dx.doi.org/10.1007/s40265-020-01341-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299245/
https://www.ncbi.nlm.nih.gov/pubmed/32557398
http://dx.doi.org/10.1007/s40265-020-01341-9

Ejemplares similares